Radiation therapy for primary orbital and ocular adnexal lymphoma

Olsen, 2019, Orbital lymphoma, Surv Ophthalmol, 64, 45, 10.1016/j.survophthal.2018.08.002 Olsen, 2019, Orbital Lymphoma-An International Multicenter Retrospective Study, Am J Ophthalmol, 199, 44, 10.1016/j.ajo.2018.11.002 White, 2019, Understanding and Classification of Ocular Lymphomas, Ocul Oncol Pathol, 5, 379, 10.1159/000499845 Salles, 2017, Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience, Adv Ther, 34, 2232, 10.1007/s12325-017-0612-x Sjö, 2009, Ophthalmic lymphoma: epidemiology and pathogenesis, Acta Ophthalmol, 87 Thesis 1, 1, 10.1111/j.1755-3768.2008.01478.x Briscoe, 2018, Characteristics of orbital lymphoma: a clinicopathological study of 26 cases, Int Ophthalmol, 38, 271 Brenner, 2020, Projected estimates of cancer in Canada in 2020, CMAJ, 192, E199, 10.1503/cmaj.191292 Yen, 2018, Treatments for Ocular Adnexal Lymphoma: A Report by the American Academy of Ophthalmology, Ophthalmology, 125, 127, 10.1016/j.ophtha.2017.05.037 Rosado, 2006, Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci, Blood, 107, 467, 10.1182/blood-2005-06-2332 Coupland, 1998, Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases, Ophthalmology, 105, 1430, 10.1016/S0161-6420(98)98024-1 Cho, 2003, Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients, Am J Hematol, 73, 87, 10.1002/ajh.10332 Ferry, 2007, Lymphoma of the ocular adnexa: A study of 353 cases, Am J Surg Pathol, 31, 170, 10.1097/01.pas.0000213350.49767.46 Goda, J.S., et al., Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys, 2011. 81(4): p. e659-66. Kalogeropoulos, 2018, Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue, Clin Exp Med, 18, 151, 10.1007/s10238-017-0474-1 Pinnix, 2017, Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma, Head Neck, 39, 1095, 10.1002/hed.24717 Demirci, 2002, Orbital tumors in the older adult population, Ophthalmology, 109, 243, 10.1016/S0161-6420(01)00932-0 Bayraktar, 2011, Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients, Br J Haematol, 152, 72, 10.1111/j.1365-2141.2010.08429.x Ferreri, 2004, Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas, J Natl Cancer Inst, 96, 586, 10.1093/jnci/djh102 Ferreri, 2006, Bacteria-eradicating therapy for ocular adnexal MALT lymphoma: questions for an open international prospective trial, Ann Oncol, 17, 1721, 10.1093/annonc/mdl124 Han, 2015, Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma, Ann Hematol, 94, 575, 10.1007/s00277-014-2240-8 Annibali, 2015, Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa, Biomed Res Int, 2015, 10.1155/2015/895105 Yahalom, 2015, Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group, Int J Radiat Oncol Biol Phys, 92, 11, 10.1016/j.ijrobp.2015.01.009 Stannard, 2013, Radiotherapy for ocular tumours, Eye (Lond), 27, 119, 10.1038/eye.2012.241 Pfeffer, 2004, Orbital lymphoma: is it necessary to treat the entire orbit?, Int J Radiat Oncol Biol Phys, 60, 527, 10.1016/j.ijrobp.2004.03.039 Binkley, 2016, Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma, Pract Radiat Oncol, 6, 255, 10.1016/j.prro.2015.11.013 Fasola, 2013, Low-dose radiation therapy (2 Gy x 2) in the treatment of orbital lymphoma, Int J Radiat Oncol Biol Phys, 86, 930, 10.1016/j.ijrobp.2013.04.035